SMAD2 and triple-negative breast carcinoma: Interestingly, we revealed that SMAD signaling was not required for the TGF-β1-induced kisspeptin expression which is different from the previous findings that the stimulatory effect of TGF-β1 on kisspeptin is mediated by SMAD2 in triple-negative breast cancer cells [19].